The Dipeptidyl Peptidase 4 Substrate CXCL12 Has Opposing Cardiac Effects in Young Mice and Aged Diabetic Mice Mediated by Ca2+ Flux and Phosphoinositide 3-Kinase γ

Diabetes
Sri N BatchuAndrew Advani

Abstract

Blood glucose-lowering therapies can positively or negatively affect heart function in type 2 diabetes, or they can have neutral effects. Dipeptidyl peptidase 4 (DPP-4) inhibitors lower blood glucose by preventing the proteolytic inactivation of glucagon-like peptide 1 (GLP-1). However, GLP-1 is not the only peptide substrate of DPP-4. Here, we investigated the GLP-1-independent cardiac effects of DPP-4 substrates. Pointing to GLP-1 receptor (GLP-1R)-independent actions, DPP-4 inhibition prevented systolic dysfunction equally in pressure-overloaded wild-type and GLP-1R knockout mice. Likewise, DPP-4 inhibition or the DPP-4 substrates substance P or C-X-C motif chemokine ligand 12 (CXCL12) improved contractile recovery after no-flow ischemia in the hearts of otherwise healthy young adult mice. Either DPP-4 inhibition or CXCL12 increased phosphorylation of the Ca2+ regulatory protein phospholamban (PLN), and CXCL12 directly enhanced cardiomyocyte Ca2+ flux. In contrast, hearts of aged obese diabetic mice (which may better mimic the comorbid patient population) had diminished levels of PLN phosphorylation. In this setting, CXCL12 paradoxically impaired cardiac contractility in a phosphoinositide 3-kinase γ-dependent manner. These ...Continue Reading

References

Jan 7, 2000·Biochemical and Biophysical Research Communications·E J MayerE McKenna
Jan 11, 2000·Circulation Research·A FrustaciP Anversa
Jun 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michio AsahiDavid H MacLennan
Jul 28, 2004·Journal of Molecular and Cellular Cardiology·Gavin Y OuditPeter H Backx
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Anthony O GramoliniDavid H Maclennan
Jun 7, 2007·The New England Journal of Medicine·Philip D HomeUNKNOWN RECORD Study Group
Jan 29, 2008·Cardiovascular & Hematological Disorders Drug Targets·Gavin Y Oudit, Zamaneh Kassiri
Nov 1, 2008·Journal of Molecular and Cellular Cardiology·S N BatchuJ M Seubert
Aug 9, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Chunyan HuangMeijing Wang
Nov 30, 2011·PloS One·Lyubov ChaykovskaBerthold Hocher
May 19, 2012·Circulation Research·Steven R HouserUNKNOWN American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Function
Jan 3, 2013·The Journal of Clinical Investigation·Andrew R Marks
Mar 19, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Ayako TakahashiMasafumi Kitakaze
Sep 3, 2013·The New England Journal of Medicine·Benjamin M SciricaUNKNOWN SAVOR-TIMI 53 Steering Committee and Investigators
Sep 3, 2013·The New England Journal of Medicine·William B WhiteUNKNOWN EXAMINE Investigators
Nov 30, 2013·International Journal of Cardiology·Heather M Dehlin, Scott P Levick
Feb 20, 2014·Frontiers in Pharmacology·Alicia Mattiazzi, Evangelia G Kranias
Apr 8, 2014·Pharmacology & Therapeutics·Daniel I BromageDerek M Yellon
May 24, 2014·Circulation Research·John R Ussher, Daniel J Drucker
Jun 16, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Annayya R AroorVincent G DeMarco
Sep 13, 2014·Endocrine Reviews·Erin E Mulvihill, Daniel J Drucker
Jun 9, 2015·The New England Journal of Medicine·Jennifer B GreenUNKNOWN TECOS Study Group
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.